US Stock MarketDetailed Quotes

PALI Palisade Bio

Watchlist
  • 1.7700
  • -0.5900-25.00%
Close Dec 13 16:00 ET
  • 1.6100
  • -0.1600-9.04%
Post 19:59 ET
2.80MMarket Cap-0.13P/E (TTM)

About Palisade Bio Company

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.

Company Profile

SymbolPALI
Company NamePalisade Bio
Listing DateAug 27, 2007
Founded2011
CEOMr. J. D. Finley
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address7750 El Camino Real,Suite 5200
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92009
Phone1-858-704-4900

Company Executives

  • Name
  • Position
  • Salary
  • J. D. Finley
  • Director, Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
  • 1.28M
  • Dr. Mitchell Lawrence Jones
  • Chief Medical Officer
  • 458.02K
  • Donald A. Williams
  • Chairman of the Board
  • 87.23K
  • Margery Fischbein
  • Independent Director
  • --
  • Binxian Wei
  • Independent Director
  • 67.63K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.